Genentech’s Fenebrutinib Shows Promise for Relapsing Multiple Sclerosis in Two-Year Study
Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), is making headway in the race to develop new treatments for multiple sclerosis (MS).
Home
Page 4
PetroTal’s Renewed Share Buyback Signals Confidence in Value
PetroTal Corp. (TSX: TAL, AIM: PTAL, OTCQX: PTALF) is once again putting its money where its management believes the value is, in its own shares.
Fairchild Gold Corp. – Nevada Titan, Unveiling District-Scale Potential in Walker Lane
Fairchild Gold Corp. (TSXV: FAIR | FRA: Y4Y) has renamed its Copper Chief Project, Nevada Titan. This name change reflects the district-scale exploration potential of
The Growing Role of AI in Modern Healthcare
Artificial intelligence in healthcare is moving from the fringes of experimentation to the core of clinical practice. No longer just an interesting side project, AI-powered
Boeing to Resume Deliveries to China Next Month, Plans to Deliver Over 170 Jets by 2027
Boeing (NYSE: BA) is set to restart airplane deliveries to China in June 2025, marking a key step toward restoring its presence in one of
U.S. Pending Home Sales Drop 6.3% in April Amid Rising Mortgage Rates and Market Uncertainty
Pending home sales in the United States fell by 6.3% in April, marking a broad decline in contract signings across all four major regions of
e.l.f. Beauty Expands Prestige Portfolio with $1 Billion Acquisition of rhode
Shares of e.l.f. Beauty (NYSE: ELF) surged more than 33% intraday to $120.81 following the announcement of its acquisition of rhode, a fast-growing lifestyle beauty
MariMed Expands Wellness Portfolio with Functional Mushroom-Infused Cannabis Products
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a prominent multi-state cannabis operator, has introduced a new line of plant-based wellness products under its Nature’s Heritage brand.
